Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia

Summary

The study will investigate in newly diagnosed CP-CML patients the efficacy of NIL frontline therapy vs IM followed by switch to NIL in the case of absence of optimal response as defined by the ELN criteria.

Timeline

Start

2016-11-11

Primary completion

2023-02

Completion

2024-02

Drugs

Indications